MedTrace Logo

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

NCT05089279 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2022-10-07

No results posted yet for this study

Summary

Study to Evaluate the Safety and Pharmacokinetics of CKD-349

Conditions

Interventions

DRUG

D113

QD, PO

DRUG

CKD-349

QD, PO

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • JaeWoo Kim · Study Principal Investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-03
Primary Completion
2022-01-18
Completion
2022-04-06

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05089279 on ClinicalTrials.gov